Fiscal Period | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
Total Liabilities Shareholders' Equity | 1,152.68 | 1,034.09 | 879.61 | 859.50 |
Cash Equivalents | 41.40 | - | - | - |
Other Liabilities Total | 1.21 | 1.16 | 1.40 | 1.57 |
Long Term Debt | 139.36 | 122.09 | 121.13 | 149.50 |
Common Stock Total | 8.87 | 8.47 | 8.47 | 8.47 |
Other Current Assets Total | 14.83 | 0.16 | 0.09 | 0.08 |
Total Assets | 1,152.68 | 1,034.09 | 879.61 | 859.50 |
Current Portof LT Debt/ Capital Leases | 171.39 | 44.69 | 38.53 | 43.74 |
Total Equity | 639.64 | 536.33 | 460.53 | 470.29 |
Long Term Investments | 18.63 | 10.94 | 10.52 | 21.53 |
Retained Earnings( Accumulated Deficit) | 630.78 | 429.47 | 382.24 | 392.01 |
Total Common Shares Outstanding | 8.87 | 8.47 | 8.47 | 8.47 |
Tangible Book Valueper Share Common Eq | 71.91 | 63.04 | 54.23 | 55.39 |
Total Liabilities | 513.04 | 497.76 | 419.08 | 389.21 |
Total Debt | 310.76 | 280.77 | 254.07 | 263.27 |
Short Term Investments | 9.89 | 0.08 | 0.07 | 12.00 |
Cashand Short Term Investments | 51.29 | 36.04 | 7.38 | 46.58 |
Total Receivables Net | 203.62 | 250.17 | 171.49 | 71.65 |
Deferred Income Tax | 48.10 | 42.80 | 41.02 | 39.55 |
Accounts Receivable- Trade Net | 203.23 | 236.61 | 148.72 | 48.53 |
Property/ Plant/ Equipment Total- Net | 565.52 | 464.87 | 443.74 | 447.63 |
Minority Interest | 0.00 | - | - | - |
Total Current Liabilities | 324.37 | 331.72 | 254.91 | 196.48 |
Total Inventory | 284.73 | 242.27 | 226.75 | 255.44 |
Accounts Payable | 113.92 | 151.32 | 113.15 | 72.86 |
Other Currentliabilities Total | 39.06 | 20.90 | 9.22 | 11.71 |
Total Long Term Debt | 139.36 | 122.09 | 121.75 | 151.62 |
Intangibles Net | 2.13 | 2.66 | 1.47 | 1.37 |
Other Long Term Assets Total | 11.94 | 7.86 | 7.62 | 7.63 |
period Length | 0.00 | 0.00 | 0.00 | 0.00 |
Total Current Assets | 554.47 | 533.89 | 410.65 | 377.05 |
Accumulated Depreciation Total | - | -190.35 | -161.67 | -130.57 |
Accrued Expenses | - | 0.82 | 0.22 | 0.26 |
Other Equity Total | - | 28.58 | - | - |
Prepaid Expenses | - | 5.25 | 4.93 | 3.31 |
Additional Paid- In Capital | - | 69.82 | 69.82 | 69.82 |
Cash | - | 35.96 | 7.31 | 34.58 |
Property/ Plant/ Equipment Total- Gross | - | 624.95 | 572.22 | 567.19 |
Notes Payable/ Short Term Debt | - | 114.00 | 93.79 | 67.91 |
Note Receivable- Long Term | - | 13.87 | 5.61 | 4.30 |
Capital Lease Obligations | - | 0.00 | 0.61 | 2.11 |
Sms Pharmaceuticals Dividend Sms Pharmaceuticals Bonus Sms Pharmaceuticals News Sms Pharmaceuticals AGM Sms Pharmaceuticals Rights Sms Pharmaceuticals Splits Sms Pharmaceuticals Board Meetings Sms Pharmaceuticals Key Metrics Sms Pharmaceuticals Shareholdings Sms Pharmaceuticals Profit Loss Sms Pharmaceuticals Cashflow Sms Pharmaceuticals Q1 Results Sms Pharmaceuticals Q2 Results Sms Pharmaceuticals Q3 Results Sms Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks